The CompanyQPS Austria is a full service contract research organization. The company performs preclinical as well as clinical research.
The preclinical research department focuses on drug development for neurodegenerative diseases. The profound expertise in neuroscience and more than a decade of experience in contract research result in a sustainable advantage for the customer.
Validated transgenic & non-transgenic in vivo & in vitro models to address new as well as already established drug targets in neurodegenerative diseases are available.
The clinical research team ensures an efficient development process from First-in-Man (Phase I) up to and including Post-Marketing-Surveillance-Studies (Phase IV). Our customers benefit from the competent teams at QPS Austria, the use of innovative technology as well as scientific and clinical expertise together with a worldwide network.
|QPS Austria GmbH, Parkring 12, A-8074 Grambach|
|Tel.: +43 316 25 8111-110 Fax: +43 316 25 8111-300|